Journal article

An analysis of NICE's 'restricted' (or 'optimized') decisions.

Phill O'Neill, Nancy J Devlin

Pharmacoeconomics | Published : 2010

Abstract

BACKGROUND: A common way of describing UK National Institute for Health and Clinical Excellence (NICE) decisions is to distinguish between cases where NICE recommended use of a healthcare technology by all relevant patients ('yes'); those where it did not recommend use ('no'); and those where its decisions are a mixture of 'yes' to some patient subgroups, and 'no' to others. Over half of NICE's decisions are of this mixed type, which involve restricting (or 'optimizing') patient use in some way. OBJECTIVE: To report an attempt to develop a robust and defensible means of measuring and describing the degree of patient access in mixed NICE decisions. METHODS: A list of mixed decisions made from..

View full abstract